Quick Answer
Solid Biosciences Inc. reported Research And Development Expense of $140.33 million for the year ending 2025.
- Solid Biosciences Inc. showed an increase of +45.5% in Research And Development Expense from 2024 to 2025.
- This data is from Solid Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Solid Biosciences Inc.'s Research And Development Expense has grown by 597.6%.
- Historical annual values: Fiscal year 2025: $140.33 million | Fiscal year 2024: $96.43 million | Fiscal year 2023: $76.56 million | Fiscal year 2022: $78.42 million | Fiscal year 2021: $58.74 million | Fiscal year 2020: $64.88 million | Fiscal year 2019: $94.74 million | Fiscal year 2018: $57.97 million | Fiscal year 2017: $39.91 million | Fiscal year 2016: $20.12 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: